Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline ; volume:132 ; number:6 ; day:21 ; month:10 ; year:2016 ; pages:875-895 ; date:12.2016
Acta neuropathologica ; 132, Heft 6 (21.10.2016), 875-895, 12.2016
- Urheber
-
Koss, David J.
- Beteiligte Personen und Organisationen
-
Jones, Glynn
Cranston, Anna
Gardner, Heidi
Kanaan, Nicholas M.
Platt, Bettina
SpringerLink (Online service)
- DOI
-
10.1007/s00401-016-1632-3
- URN
-
urn:nbn:de:1111-2016120412634
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koss, David J.
- Jones, Glynn
- Cranston, Anna
- Gardner, Heidi
- Kanaan, Nicholas M.
- Platt, Bettina
- SpringerLink (Online service)
Ähnliche Objekte (12)
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Alzheimer’s disease and the β-amyloid peptide : Aβ conformers and mechanisms of spreading
CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
Abnormal EEG microstates in Alzheimer’s disease: predictors of β-amyloid deposition degree and disease classification
β-amyloid seeds : primitive and durable pathological entities in Alzheimer's disease
Endocytosis and Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Cerebrovascular disease in ageing and Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Alzheimer’s disease and the β-amyloid peptide : Aβ conformers and mechanisms of spreading
CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
Abnormal EEG microstates in Alzheimer’s disease: predictors of β-amyloid deposition degree and disease classification
β-amyloid seeds : primitive and durable pathological entities in Alzheimer's disease
Endocytosis and Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
Cerebrovascular disease in ageing and Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Alzheimer’s disease and the β-amyloid peptide : Aβ conformers and mechanisms of spreading
CryoET of β-amyloid and tau within postmortem Alzheimer’s disease brain
Abnormal EEG microstates in Alzheimer’s disease: predictors of β-amyloid deposition degree and disease classification
β-amyloid seeds : primitive and durable pathological entities in Alzheimer's disease
Endocytosis and Alzheimer’s disease
Alzheimer’s disease and immunotherapy
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Microglial Lyzl4 Facilitates β‐Amyloid Clearance in Alzheimer's Disease
CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease